Biomerica, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
BMRA Nasdaq 3841 http://www.biomerica.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biomerica, Inc.

BMRA: Q1 2019: Asia Strong, Europe & U.S. Weak. Revenue up 13% QoQ But Down 12% yoy. Expense Control Minimizes Op Loss. - Oct 22nd, 2018 11:15 am
Biomerica Reports 1st Quarter Fiscal 2019 Financials - Oct 16th, 2018 6:30 am
Is Biomerica Inc (NASDAQ:BMRA) A Financially Sound Company? - Sep 26th, 2018 10:00 am
BMRA: Legacy Biz Slows in Q4. Operational Highlights Include InFoods Enrolling, Ex-Walgreens CMO Joins SAB (and we’re intrigued) - Sep 7th, 2018 8:00 am
Biomerica Announces Fiscal Year End 2018 Financial Results - Aug 30th, 2018 6:19 am
Biomerica Receives Notice of Allowance for Irritable Bowel Syndrome (IBS) Test Panel and Methods in Korea - Aug 2nd, 2018 6:19 am
When Can We Expect A Profit From Biomerica Inc (NASDAQ:BMRA)? - May 31st, 2018 6:26 pm
Should You Be Concerned About Biomerica Inc’s (NASDAQ:BMRA) Shareholders? - May 10th, 2018 3:55 pm
BMRA: Q3 2018 Results: Asia Remains Strong While U.S., Europe Slip. Encouraged By Robustness of InFoods Study Design - Apr 19th, 2018 7:45 am
Does Biomerica Inc’s (NASDAQ:BMRA) Past Performance Indicate A Stronger Future? - Apr 17th, 2018 1:01 pm
Biomerica Inc (NASDAQ:BMRA): Is Breakeven Near? - Mar 1st, 2018 4:11 pm
BMRA: Moving Price Target to $7/Share With Inclusion of InFoods - Jan 23rd, 2018 7:45 am
Biomerica Inc (NASDAQ:BMRA): Poised For Long-Term Success? - Jan 9th, 2018 6:43 am